home All News open_in_new Full Article

Ostia Sciences Inc. Completes $1.46M Seed Round to Develop Microbiome Therapeutics Platform.

The company receives additional non-dilutive funding from Natural Products Canada. TORONTO — Ostia Sciences Inc., a microbiome therapeutics company developing next-generation probiotics, today announced the successful close of its seed financing round, raising CAD $1.46 million as of December 31, 2024. In addition to private investment, Ostia secured over $393,000 in non-dilutive grants, including $350,000 […]


today 46 h. ago attach_file Economics

attach_file Other
attach_file Events
attach_file Events
attach_file Other
attach_file Events
attach_file Economics
attach_file Sport
attach_file Transport
attach_file Sport
attach_file Other
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Economics


ID: 4209438569
Add Watch Country

arrow_drop_down